A 6-week, double-masked, paralle-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
Wendy A. Franks, Jean P. Renard, Ian A. Cunliffe, Prin RojanapongpunVolume:
28
Année:
2006
Langue:
english
Pages:
340
DOI:
10.1016/j.clinthera.2006.03.001
Fichier:
PDF, 881 KB
english, 2006